10-K: SCWorx Corp. Reports Annual Results: Revenue Declines, Net Loss Narrowed in 2024

SCWorx Corp. reports a decrease in revenue but a reduced net loss for the year ended December 31, 2024, amid concerns about its ability to continue as a going concern.

Summary

• SCWorx Corp. reported a revenue of $2,989,599 for the year ended December 31, 2024, a decrease of approximately $815,000 (21%) compared to $3,804,943 in 2023.
• The company's net loss decreased from $3,981,144 in 2023 to $1,136,225 in 2024.
• As of December 31, 2024, SCWorx had a working capital deficit of $1,333,171 and an accumulated deficit of $30,976,066.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• SCWorx is focusing on expanding its sales force, product offerings, and project capabilities to drive growth.
• The company entered into a securities purchase agreement on January 17, 2025, for gross proceeds of $1,500,000 to address liquidity concerns and fund future growth.
• The company plans to generate positive operating cash flows by the end of 2025 through new customer acquisition.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the net loss has decreased, the revenue decline and going concern warning from the auditors raise significant concerns. The recent capital raise is a positive sign, but the overall outlook remains uncertain.

Positives

• The net loss decreased significantly from 2023 to 2024.
• Operating expenses decreased by $714,329 in 2024 compared to 2023.
• The company secured additional funding of $1,500,000 in January 2025.
• SCWorx is actively pursuing growth strategies, including expanding its sales force and product offerings.
• The company is aiming to generate positive operating cash flows by the end of 2025.

Negatives

• Revenue decreased by 21% in 2024 compared to 2023.
• The company has a working capital deficit of $1,333,171.
• Auditors have expressed substantial doubt about the company's ability to continue as a going concern.
• The company has a history of losses and may continue to incur losses in the future.
• The company's customer base is highly concentrated.

Risks

• The company's ability to continue as a going concern is uncertain.
• SCWorx may need additional capital, and there is no guarantee that it will be available on acceptable terms.
• The company's customer base is highly concentrated, and the loss of one or more significant customers could adversely affect its business.
• The industry is highly competitive, and the company's failure to compete effectively could reduce the number of new contracts awarded.
• Economic downturns could cause capital expenditures in the industries SCWorx serves to decrease.
• The company's operating results may fluctuate due to factors that are difficult to forecast and not within its control.
• The company may be involved in lawsuits and regulatory actions, which could result in substantial costs and penalties.
• The company's common stock price has fluctuated substantially and is likely to continue to be volatile.

Future Outlook

SCWorx intends to utilize the funds from the January 2025 securities purchase agreement to pursue growth through the expansion of its sales force, product offering, and project capabilities, and believes it may begin to generate positive operating cash flows by the end of 2025.

Management Comments

• Management believes that governmental regulation is not material to our current core data management business.
• Management conducted an evaluation of the effectiveness of our disclosure controls and procedures.
• Management has identified material weaknesses in our internal controls related to a lack of segregation of duties.
• Management continues to work with the Audit Committee to discuss remediation efforts.

Industry Context

The report mentions that the medical industry is subject to rapid changes in technology and governmental regulation, and is characterized by a high level of consolidation that may result in the loss of one or more of SCWorx's customers.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or benchmarks.
• The document mentions that SCWorx competes against a variety of vendors and smaller companies which provide solutions in the specific markets we address.
• The document mentions that some of our actual and perceived competitors have advantages over us, such as longer operating histories, greater financial, technical, marketing or other resources, stronger brand and business user recognition, larger intellectual property portfolios, broader distribution and presence, and competitive pricing.

Management Changes

Corporate Governance

Legal Proceedings

• The Company and Core IR entered into a settlement agreement dated July 12, 2024 under which the Company agreed to issue Core IR shares of its common stock with a value of $502,000 (determined based on sales proceeds realized by Core IR), in full and complete satisfaction of the Judgement.
• Plaintiff has since entered into a settlement agreement dated December 1, 2023 (effective as of October 23, 2023) (as amended April 29, 2024), under which the Company agreed to pay Plaintiffs $20,000 and issue them 37,500 shares of common stock, all in full settlement of the claims made in the lawsuit.

Related Party Transactions

• At December 31, 2024 and 2023 Company had aged payables that were due to officers in the amount of $149,838.
• During September 2021, the Companys former CEO (also a significant shareholder) advanced $100,000 in cash to the Company for short term capital requirements.
• Between January 18, 2024 and July 11, 2024, the Companys CFO advanced an aggregate $128,479 in cash to the Company for short term capital requirements.

Stakeholder Impact

• Shareholders face the risk of further stock dilution due to potential future equity offerings.
• Employees may be affected by cost-cutting measures or restructuring if the company's financial situation does not improve.
• Customers may be concerned about the company's long-term viability and its ability to provide ongoing support and services.
• Creditors face increased risk of non-payment due to the company's financial difficulties.

Next Steps

• SCWorx intends to utilize the funds from the January 2025 securities purchase agreement to pursue growth through the expansion of its sales force, product offering, and project capabilities.
• The company plans to generate positive operating cash flows by the end of 2025 through new customer acquisition.
• Management continues to work with the Audit Committee to discuss remediation efforts related to material weaknesses in internal controls.

Key Dates

Keywords

healthcare data, data normalization, interoperability, SaaS, financial results, SCWorx, going concern, revenue, net loss, risk factors